- Home
- DRUG vs RCKY Comparison
DRUG vs RCKY Comparison
Compare DRUG & RCKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- RCKY
- Stock Information
- Founded
- DRUG 2019
- RCKY 1932
- Country
- DRUG United States
- RCKY United States
- Employees
- DRUG N/A
- RCKY N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- RCKY Shoe Manufacturing
- Sector
- DRUG Health Care
- RCKY Consumer Discretionary
- Exchange
- DRUG Nasdaq
- RCKY Nasdaq
- Market Cap
- DRUG 199.7M
- RCKY 196.3M
- IPO Year
- DRUG N/A
- RCKY 1993
- Fundamental
- Price
- DRUG $43.96
- RCKY $27.90
- Analyst Decision
- DRUG Strong Buy
- RCKY Hold
- Analyst Count
- DRUG 8
- RCKY 1
- Target Price
- DRUG $83.60
- RCKY $30.00
- AVG Volume (30 Days)
- DRUG 53.0K
- RCKY 76.2K
- Earning Date
- DRUG 08-11-2025
- RCKY 07-29-2025
- Dividend Yield
- DRUG N/A
- RCKY 2.33%
- EPS Growth
- DRUG N/A
- RCKY 24.23
- EPS
- DRUG N/A
- RCKY 2.48
- Revenue
- DRUG N/A
- RCKY $462,328,000.00
- Revenue This Year
- DRUG N/A
- RCKY $6.67
- Revenue Next Year
- DRUG N/A
- RCKY $4.25
- P/E Ratio
- DRUG N/A
- RCKY $11.26
- Revenue Growth
- DRUG N/A
- RCKY N/A
- 52 Week Low
- DRUG $0.94
- RCKY $11.93
- 52 Week High
- DRUG $79.02
- RCKY $33.04
- Technical
- Relative Strength Index (RSI)
- DRUG 69.20
- RCKY 63.27
- Support Level
- DRUG $34.19
- RCKY $25.76
- Resistance Level
- DRUG $46.13
- RCKY $27.69
- Average True Range (ATR)
- DRUG 3.38
- RCKY 1.13
- MACD
- DRUG 0.26
- RCKY -0.04
- Stochastic Oscillator
- DRUG 82.17
- RCKY 73.53
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.